Robert L. Sutherland

27.7k citations
237 papers · 19.3k · 3 hit papers · h-index 78

Impact in

  • Oncology top 0.1%
    • Cancer-related Molecular Pathways
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis

Papers in

    • Epigenetics and DNA Methylation 17
    • Retinoids in leukemia and cellular processes 13
    • Cancer-related Molecular Pathways 48
    • HER2/EGFR in Cancer Research 16
    • Cytokine Signaling Pathways and Interactions 11

Robert L. Sutherland

235 papers receiving 18.9k citations

Robert L. Sutherland's Hit Papers

Cyclin D as a therapeutic target in cancer 2011 · 1.1k citations
1.1k0+12+24Years since publication2505007501000

Peers

Robert L. Sutherland
Comparison fields: 5 of 144
  • Oncology 6.7k
  • Cancer Research 3.2k
  • Genetics 4.6k
  • Molecular Biology 9.4k
  • Pulmonary and Respiratory Medicine 2.8k
Replace Robert I. Nicholson with:
Robert I. Nicholson United Kingdom
Suzanne A.W. Fuqua United States
Elizabeth A. Musgrove Australia
John T. Isaacs United States
C. Kent Osborne United States
Andres J. Klein–Szanto United States
Domenico Coppola United States
Geoffrey J. Lindeman Australia
Robert B. Dickson United States
Weiya Xia United States
Robert L. Sutherland relative to Robert I. Nicholson United Kingdom Robert I. Nicholson's profile →
Citations per field
00.5×1.5×
Robert I. Nicholson · 1×
Citations per year

Countries citing papers authored by Robert L. Sutherland

Since Specialization
Citations

This map shows the geographic impact of Robert L. Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Sutherland more than expected).

Fields of papers citing papers by Robert L. Sutherland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Sutherland. The network helps show where Robert L. Sutherland may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert L. Sutherland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert L. Sutherland Line = papers co-authored together Robert L. Sutherland links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cyclin D as a therapeutic target in cancer
Hit paper breakdown →
20111100
2
Biological determinants of endocrine resistance in breast cancer
Hit paper breakdown →
2009995
3
Progestin Regulation of Cellular Proliferation*
Hit paper breakdown →
1990543
4 2003398
5 1997377
6 1980325
7 2009309
8 1999260
9 2009249
10 2009248
11
Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
1983243
12 2009240
13 2010234
14 1998218
15 2005195
16 2003192
17
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.
2003191
18 2004188
19 2005186
20 1983177

About Robert L. Sutherland

Robert L. Sutherland is a scholar working on Molecular Biology, Oncology, Genetics, Pulmonary and Respiratory Medicine and Cancer Research, having authored 237 papers that have together received 19.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (64 papers), Cancer-related Molecular Pathways (48 papers), Epigenetics and DNA Methylation (17 papers), HER2/EGFR in Cancer Research (16 papers), Prostate Cancer Treatment and Research (15 papers), Retinoids in leukemia and cellular processes (13 papers), Advanced Breast Cancer Therapies (13 papers) and Cytokine Signaling Pathways and Interactions (11 papers). The work is most often cited by research in Oncology (6.7k citations), Cancer Research (3.2k citations), Genetics (4.6k citations), Molecular Biology (9.4k citations) and Pulmonary and Respiratory Medicine (2.8k citations). Robert L. Sutherland has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Elizabeth A. Musgrove, Susan M. Henshall, Christine L. Clarke, C. Elizabeth Caldon, Leigh C. Murphy, Roger J. Daly, Andrew Stone, Roger R. Reddel, Jane Barraclough and Rosemary E. Hall. Their work appears in journals such as International Journal of Cancer, Cancer Epidemiology Biomarkers & Prevention, Journal of Biological Chemistry, Cancer Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact